European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

Health system lawyers are silent on why hospitals don't keep AI scribe transcripts for quality and accuracy research.

AC Immune said its immunotherapy showed the potential to slow the progression of Parkinson’s disease, based on preliminary ...

Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, ...

At a health care AI summit in Washington D.C. yesterday, heavy hitters weighed in on the prospects for interoperability — the ...

In the past twenty years, the number of hospitals that are capable of treating kids and adolescents has dropped significantly ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

A raging bull market for biotech stocks and a good story have transformed an ineffective weight loss drug into a Wall Street ...

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

The rise of anti-science and anti-vaccine rhetoric has fundamentally changed the relationship between clinicians and patients.” ...